Stockreport

Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicin [Read more]